首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Mechanism of Reduced Vancomycin Susceptibility Conferred by walK Mutation in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strain MW2
【2h】

Mechanism of Reduced Vancomycin Susceptibility Conferred by walK Mutation in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strain MW2

机译:walK突变在社区获得的耐甲氧西林金黄色葡萄球菌菌株MW2中降低万古霉素敏感性的机理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Point mutations with unclear molecular mechanisms are often associated with vancomycin resistance in Staphylococcus aureus. Here, we observed that the walK (G223D) mutation caused decreased expression of genes associated with cell wall metabolism, decreased autolytic activity, thickened cell walls, and reduced vancomycin susceptibility. A phosphorylation assay showed that WalK (G223D) exhibited reduced autophosphorylation, which led to reduced phosphorylation of WalR. An electrophoretic mobility shift assay indicated that WalK (G223D)-phosphorylated WalR had a reduced capacity to bind to the atlA promoter.
机译:分子机制不清楚的点突变通常与金黄色葡萄球菌对万古霉素的耐药性有关。在这里,我们观察到walK(G223D)突变引起与细胞壁代谢相关的基因表达降低,自溶活性降低,细胞壁增厚和万古霉素敏感性降低。磷酸化分析表明,WalK(G223D)表现出降低的自身磷酸化作用,从而导致WalR的磷酸化作用降低。电泳迁移率变动分析表明,WalK(G223D)-磷酸化的WalR与atlA启动子结合的能力降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号